Nader brings over eight years of expertise in pricing and market access, supporting pharmaceutical companies with strategy, value communication and organisational transformation.

Nader has 8+ years of experience in pricing and market Access consulting where he has gained expertise in leading and executing multiple project types including pipeline asset pricing and access opportunity assessments, developing and refining payer value propositions, organising and facilitating payer mock negotiation and objection handling workshops, and organisational transformation for Pricing and Market Access functions within pharma companies. His therapy area experience spans across Oncology, Autoimmune, Rare, and Chronic Metabolic diseases.

Nader Holds and MSc from Imperial College Business School in International Health Management.

‍

“I am committed to helping patients, healthcare systems and pharma to identify sustainable solutions for healthcare innovation and access.”